Title of article :
Serum trypsin inhibitory capacity in hemodialysis patients
Author/Authors :
Hashemi, Mohammad zahedan university of medical sciences - Department of Clinical Biochemistry, زاهدان, ايران , Mehrabifar, Hamid zahedan university of medical sciences - Bou Ali Hospital - Research Center for Infectious Diseases and Tropical Medicine, زاهدان, ايران , Homayooni, Fatemeh zahedan university of medical sciences - Bou Ali Hospital - Research Center for Infectious Diseases and Tropical Medicine, زاهدان, ايران , Naderi, Mohammad zahedan university of medical sciences - Bou Ali Hospital - Research Center for Infectious Diseases and Tropical Medicine, زاهدان, ايران , Montazerifar, Farzaneh zahedan university of medical sciences - School of Medicine - Department of Nutrition, زاهدان, ايران , Ghavami, Saeid University of Manitoba - Manitoba Institute of Cell Biology - Department of Biochemistry and Medical Genetics, Canada
From page :
604
To page :
607
Abstract :
It has been established that overproduction of reactive oxygen species (ROS) occurs during hemodialysis causing oxidation of proteins. Alpha-1-antitrypsin is the major circulating anti­protease which contains methionine in the active site. The aim of the present study was to measure the level of serum trypsin inhibitory capacity (sTIC) in hemodialysis patients. This case-control study was performed in 52 hemodialysis patients and 49 healthy controls. sTIC was measured by enzymatic assay. The sTIC was significantly (P 0.001) lower in hemodialysis patients (1.87 ± 0.67 µmol/min/mL) than healthy controls (2.83 ± 0.44 µmol/min/L). Reduction of sTIC may be due to the oxidation of methionine residue in the reactive site of alpha-1 antitrypsin.
Keywords :
Alpha , 1 Anitrypsin , Hemodialysis , Chronic renal failure , Serum trypsin inhibitory capacity
Journal title :
Saudi Journal of Kidney Diseases and Transplantation
Journal title :
Saudi Journal of Kidney Diseases and Transplantation
Record number :
2674758
Link To Document :
بازگشت